Trial
NCT04699968
A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Non-Small-Cell Lung Cancer
Intervention
SHR-1701，Famitinib
Why stopped
Sponsor R \& D Strategy Adjustment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-07